Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;24(8):671-680.
doi: 10.1007/s11883-022-01042-6. Epub 2022 May 28.

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions

Melody Hermel  1 , Stacy Tsai  1 , Luis Dlouhy  2 , Anupama B K  2 , Jamal S Rana  3 , Sourbha S Dani  4 , Salim S Virani  5   6   7
Affiliations
Review

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions

Melody Hermel et al. Curr Atheroscler Rep. 2022 Aug.

Abstract

Purpose of review: Focused review highlighting select studies presented at the 2022 American College of Cardiology (ACC) Scientific Sessions.

Recent findings: Included studies assessed the impact of a low-sodium diet on heart failure outcomes (SODIUM-HF); outcomes of pregnant patients with chronic hypertension treated with antihypertensive therapies (CHAP); cardiovascular outcomes in patients with type 2 diabetes and renal impairment treated with sotagliflozin (SCORED); a safety and efficacy study investigating SLN360, a short interfering RNA targeting lipoprotein(a) (APOLLO); a supermarket and web-based intervention targeting nutrition for cardiovascular risk reduction (SuperWIN); a superiority trial comparing myocardial injury following very mild perioperative hypothermia versus aggressive warming after non-cardiac surgery (PROTECT); and 3-year efficacy outcomes of renal denervation on blood pressure reduction from the SPYRAL HTN-ON MED pilot study. Research presented at the 2022 ACC Scientific Sessions underscores the new potential and meaningful impact of cardiovascular disease prevention and management interventions.

Keywords: Cardiovascular prevention; DASH diet; Heart failure; Hypertension; Lipoprotein(a); Sotagliflozin.

PubMed Disclaimer

Conflict of interest statement

Melody Hermel, Stacy Tsai, Luis Dlouhy, Anupama B K, Jamal S. Rana, Sourbha S. Dani: None.

Salim S. Virani: Honorarium, American College of Cardiology (Associate Editor for Innovations, acc.org), Section Editor for Current Atherosclerosis Reports.

References

    1. Tita AT, Szychowski JM, Boggess K, et al. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 doi: 10.1056/NEJMoa2201295. - DOI - PubMed
    1. Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. N Engl J Med. 2021;384:129–139. doi: 10.1056/NEJMoa2030186. - DOI - PubMed
    1. Lee MT, George J, Shahab H, Hermel M, Rana JS, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2022;24:61–72. doi: 10.1007/s11883-022-00985-0. - DOI - PMC - PubMed
    1. Lee MT, Mahtta D, Dlouhy L, Shahab H, Al Rifai M, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress. Curr Atheroscler Rep. 2021;23:76. doi: 10.1007/s11883-021-00975-8. - DOI - PubMed
    1. Jain V, Al Rifai M, Mahtta D, Liu J, Hussain A, Virani SS. Highlights from studies presented at the virtual american college of cardiology scientific sessions 2021: staying updated with the latest advancements in prevention. Curr Atheroscler Rep. 2021;23:50. doi: 10.1007/s11883-021-00952-1. - DOI - PMC - PubMed